Advances in stent-mediated gene delivery

References

• Sharif F, Daly K, Crowley J, O’Brien T. Current status of catheter- and stent-based gene therapy. Cardiovasc Res. 2004;64:208–216. doi:10.1016/j.cardiores.2004.07.003.
   PubMed Web of Science ®Google Scholar
• Yin R-X, Yang D-Z, Wu J-Z. Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis. Theranostics. 2014;4:175–200. doi:10.7150/thno.7210.
   PubMed Web of Science ®Google Scholar
• Chang H, Ren KF, Zhang H, et al. The (PrS/HGF-pDNA) multilayer films for gene-eluting stent coating: gene-protecting, anticoagulation, antibacterial properties, and in vivo antirestenosis evaluation. J Biomed Mater Res B Appl Biomater. 2015;103(2):430–439. doi:10.1002/jbm.b.33224.
   PubMed Web of Science ®Google Scholar
• Walter DH1, Cejna M, Diaz-Sandoval L, et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation. 2004;110:36–45. [ Epub 2004 Jun 21]. doi:10.1161/01.CIR.0000133324.38115.0A.
   PubMed Web of Science ®Google Scholar
• Sharif F, Hynes SO, McCullagh KJA, et al. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model. Gene Ther. 2012;19:321–328. doi:10.1038/gt.2011.92.
   PubMed Web of Science ®Google Scholar
• Wang X, Niu D, Hu C, et al. Polyethyleneimine-based nanocarriers for gene delivery. Curr Pharm Des. 2015 Oct 27;21(42):6140–6156. doi:10.2174/1381612821666151027152907.
   Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012 Jul 20;161(2):505–522.
   PubMed Web of Science ®Google Scholar
• Jin L, Zeng X, Liu M, et al. Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics. 2014;4:240–255. doi:10.7150/thno.6914.
   PubMed Web of Science ®Google Scholar
• Brito LA1, Chandrasekhar S, Little SR, et al. In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents. J Biomed Mater Res A. 2010;93(1):325–336. doi:10.1002/jbm.a.32488.
   PubMed Web of Science ®Google Scholar
• Cohen-Sacks H1, Najajreh Y, Tchaikovski V, et al. Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Ther. 2002;9(23):1607–1616. doi:10.1038/sj.gt.3301830.
   PubMed Web of Science ®Google Scholar
• Kumar Singh R, Chamberlain JS. Encapsidated adenovirus mini chromosomes allow delivery and expression of a 14KB dystrophin cDNA to muscle cells. Hum Mol Genet. 1996;5:913–921. doi:10.1093/hmg/5.7.913.
   PubMed Web of Science ®Google Scholar
• Fishbein I, Forbes SP, Adamo RF, et al. Vascular gene transfer from metallic stent surfaces using adenoviral vectors tethered through hydrolysable cross-linkers. J Vis Exp. 2014;90:e51653.
   Google Scholar
• Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated vectors. J Virol. 1996;70:8098–8108.
   PubMed Web of Science ®Google Scholar
• Sharif F, Hynes SO, McMahon J, et al. Gene-eluting stents: comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo. Hum Gene Ther. 2006;17(7):741–750. doi:10.1089/hum.2006.17.741.
   PubMed Web of Science ®Google Scholar
• Bonci D, Cittadini A, Latronico MVG, et al. ‘Advanced’ generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther. 2003;10(8):630–636. doi:10.1038/sj.gt.3301886.
   PubMed Web of Science ®Google Scholar
• Yang Z, Simari R, Perkins N, et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA. 1996;93:7905–7910. doi:10.1073/pnas.93.15.7905.
   PubMed Web of Science ®Google Scholar
• Rincon MY, VandenDriessche T, Chuah MK. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Cardiovasc Res. 2015;108(1):4–20. doi:10.1093/cvr/cvv205.
   PubMed Web of Science ®Google Scholar
• Mudau M, Genis A, Lochner A, et al. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 2012;23:222–231. doi:10.5830/CVJA-2011-068.
   PubMed Web of Science ®Google Scholar
• Numaguchi Y, Okumura K, Harada M, et al. Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries. Cardiovasc Res. 2004;61:177–185.
   PubMed Web of Science ®Google Scholar
• Puhakka HL, Turunen P, Rutanen J, et al. Tissue inhibitor of metalloproteinase 1 adenoviral gene therapy alone is equally effective in reducing restenosis as combination gene therapy in a rabbit restenosis model. J Vasc Res. 2005;42(5):361–367. Epub 2005 Jul 19. doi:10.1159/000087120.
   PubMed Web of Science ®Google Scholar
• Yin X, Fu Y, Yutani C, et al. HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries. Int J Cardiol. 2009;135:245–248. doi:10.1016/j.ijcard.2008.02.009.
   PubMed Web of Science ®Google Scholar
• Halvorsen B, Waehre T, Scholz H, et al. Role of interleukin-10 in atherogenesis and plaque stabilization. Future Cardiol. 2006;2:75–83. doi:10.2217/14796678.2.1.75.
   PubMedGoogle Scholar
• Yang J1, Zeng Y, Zhang C, et al. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent. Biomaterials. 2013;34(6):1635–1643.
   Google Scholar